RR

Rajiv Ranjan

Active Director Director DIN 09619841
DIN 09619841 First appointment May 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajiv Ranjan

Data last updated:

Rajiv Ranjan is a Director at Panaceya Medicare Private Limited (since 2022). The company operates in Healthcare.

DIN 09619841
Primary Designation Director
Industry Healthcare
First Appointment 25 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Panaceya Medicare Private Limited U85100BR2022PTC058176
Director25 May 20222022Active

Board colleagues of Rajiv Ranjan

Directorship timeline

Open interactive timeline →
Panaceya Medicare Private Limited
Premium access

Shareholding and investment profile for Rajiv Ranjan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajiv Ranjan

Rajiv Ranjan currently holds 1 directorship: Panaceya Medicare Private Limited (Director, since 25 May 2022).

Rajiv Ranjan was first appointed on 25 May 2022 as Director at Panaceya Medicare Private Limited.

The current boards of Rajiv Ranjan's companies include Ajay Chaudhri (Panaceya Medicare Private Limited), Manoj Kumar (Panaceya Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available